Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.49 USD | +3.02% | +18.86% | +80.69% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+80.69% | 648M | |
+18.17% | 125B | |
+14.21% | 109B | |
-2.20% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.43% | 16.64B | |
+0.10% | 13.45B | |
+23.46% | 11.32B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Transcript : Cartesian Therapeutics, Inc., Selecta Biosciences, Inc. - M&A Call